CMT-LBP: Cognitive Muscular Therapy for Low Back Pain

Sponsor
University of Salford (Other)
Overall Status
Recruiting
CT.gov ID
NCT05611476
Collaborator
(none)
15
1
1
10.8
1.4

Study Details

Study Description

Brief Summary

The primary aim of this study is to adapt Cognitive Muscular Therapy so that it can be used to manage chronic low back pain. A secondary aim is to understand the potential therapeutic benefit of this intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Muscular Therapy for low back pain
N/A

Detailed Description

There is evidence that people with chronic low back pain (LBP) demonstrate muscle overactivity during functional tasks when compared to healthy controls. Interestingly, this increased activity of the low back and trun, muscles has been associated with increased sensitivity to pain. It has also been shown that people with chronic LBP exhibit alterations in functional movement patterns and postures when compared to healthy people. Such alterations may be a direct result of increased stiffness in the spine which results from muscle overactivity. Psychosocial physiotherapy techniques for LBP are gaining widescale acceptance. However, these approaches are often combined with strengthening exercises, and not specifically aimed at reducing muscle overactivity. Therefore, there is a need for research into interventions for chronic LBP which integrate psychologically informed practice with training to reduce muscle overactivity.

The investigators have developed a new treatment for people with knee osteoarthritis, known as Cognitive Muscular Therapy (CMT). CMT is a form of psychologically informed physiotherapy which uses biofeedback training to reduce muscle overactivity and therefore lower the mechanical stress on the knee. CMT is delivered through five sequential intervention components and teaches patients to think and respond differently to pain, to improve postural control and to perform functional movements, such as walking, with less muscle tension. See the dedicated website for further details (https://hub.salford.ac.uk/cognitive-muscular-therapy/). Given the strong focus on postural control, the investigators are confident that CMT can be adapted and used to treat other chronic musculoskeletal conditions, such as LBP. In this project, the investigators will map changes to the five CMT intervention components. The intervention will then be delivered to patients with chronic low back pain, after which the investigators will seek to understand participant perceptions of the new treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
The primary aim is to develop the intervention. We will do this through delivery of the intervention to three waves of patients. After each of the first two waves, the intervention will be adapted based on participant feedbackThe primary aim is to develop the intervention. We will do this through delivery of the intervention to three waves of patients. After each of the first two waves, the intervention will be adapted based on participant feedback
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cognitive Muscular Therapy for Low Back Pain
Actual Study Start Date :
Dec 8, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single group

This group will receive Cognitive Muscular Therapy for low back pain

Behavioral: Cognitive Muscular Therapy for low back pain
Psychologically informed physiotherapy which used biofeedback training to reduce muscle overactivity and improve postural control

Outcome Measures

Primary Outcome Measures

  1. Change in Rowland Morris Disability questionnaire [Change from baseline to 2 months]

    Used to capture pain/disability associated with low back pain. Score 0-24 (0=no pain, 24=maximum pain)

Secondary Outcome Measures

  1. Change in Pain catastrophizing scale [Change from baseline to 2 months]

    Used to capture pain catastrophizing behaviours. Score 0-52 (0=no pain catastrophizing, 52=maximum pain catastrophizing)

  2. Change in Tampa scale of kinesiophobia [Change from baseline to 2 months]

    Used to capture kinesiophobia behaviours. Score 17-68 (0=no kinesiophobia, 52=maximum kinesiophobia)

  3. Change in Oswestry disability scale [Change from baseline to 2 months]

    Used to capture intensity of low back pain. Score 0-100 (0=no pain)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Above 18 years old

  2. Speak and understand English sufficient to read the information sheet and sign the consent form

  3. Ability to walk without an assistive device for at least 100m (to ensure patients have sufficient mobility to be able to complete the intervention)

  4. Low back pain for at least three months' duration

  5. Currently scoring 4 or more on the Roland disability scale

Exclusion Criteria:
  1. Dementia or other major cognitive impairment

  2. Red flags (specific causes of LBP, such as acute disc prolapse with radicular pain, or other serious pathology)

  3. Pregnancy

  4. History of serious spinal injury (fractures, spinal cord injury)

  5. BMI >33 (as EMG measurement is not possible in people with higher BMI)

  6. Acute low back pain (Onset less than 3 months)

  7. Any systemic inflammatory disorders, such as rheumatoid arthritis

  8. Any balance disorders which may increase the risk of a fall

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Salford Manchester Greater Manchester United Kingdom M6 6PU

Sponsors and Collaborators

  • University of Salford

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Stephen Preece, Professor of Biomechanics and Rehabilitation, University of Salford
ClinicalTrials.gov Identifier:
NCT05611476
Other Study ID Numbers:
  • CMT-LBP-6581
First Posted:
Nov 10, 2022
Last Update Posted:
Dec 13, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stephen Preece, Professor of Biomechanics and Rehabilitation, University of Salford
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 13, 2022